Lutetium+177

Lutetium-177 is an isotope that can be used in modern day medicine. It is mostly related to the study of cancer treatments. Lutetium works related to Yttrium-90 but it is much more effective because the gamma rays of lutetium are shorter than yttrium, making the lutetium useful for smaller tumors. Also, lutetium has both gamma and beta properties which enables both treatment and imaging purposes for future researches. Lutetium-177 is currently being investigated in more than 30 different clinical applications including treatment of colon cancer, metastatic bone cancer, non-Hodgkin's lymphoma and lung cancer. Clinical research with lutetium-177 has been ongoing for several years and the isotope has demonstrated certain chemical and radiological properties which make it potentially very well suited as a cancer therapy product. Its half life is 6.6475(20) d. Also lutetium has been more readily presented for the public in these recent years. It is commonly purchasable in pharmaceutical companies. Original lutetium atomic arrangement. Lutetium solid rock. Sources: http://www.in-pharmatechnologist.com/Processing-QC/New-lutetium-177-source-for-cancer-drugs http://las.perkinelmer.com/Catalog/FamilyPage.htm?CategoryID=Lutetium-177